Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announces its participation in the Jefferies Global Healthcare Conference 2025. Members of its executive team will participate in one-on-one meetings and present on Monday, November 17, 2025.
Jefferies Global Healthcare Conference
Date: November 17, 2025
Time: 2:30–2:55 PM GMT / 9:30–9:55 AM ET / 3:30–3:55 PM CET
Location: London, UK
A live webcast will be available on the Events page in the Investors section of Innate Pharma website.
| Communiqué de presse en français | 110.93 KB |
| Press release in English | 116.87 KB |